secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seer, Inc. (SEER)
CIK:        0001726445
Form:       8-K
Filed at:   2021-11-29T23:59:59+00:00
Accession:  0001628280-21-024168
Event type: leadership
Sentiment:  positive
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seer appoints Meeta Gulyani to Board of Directors; brings life sciences industry experience from Merck KGaA
--------------------------------------------------------------------------------

- Appointed Meeta Gulyani as Class III director with term expiring at 2023 annual meeting.
- Gulyani is EVP, Head of Strategy, Business Development & Transformation for Merck KGaA's Life Science business (MilliporeSigma).
- Received initial stock option for 30,000 shares vesting monthly over 3 years; annual cash retainer of $40,000.
- Board expanded from nine to ten directors effective November 29, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726445/000162828021024168/0001628280-21-024168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726445/000162828021024168/seer-20211129.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-024168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer